The function of the human T-cell leukemia virus (HTLV) Rex
phosphoprotein is to increase the level of the viral structural and
enzymatic gene products expressed from the incompletely spliced viral
RNAs containing the Rex-responsive element. The phosphorylation of HTLV
type 2 Rex (Rex-2), predominantly on serine residues, correlates with
an altered conformation, as detected by a gel mobility shift, and is
required for specific binding to its viral RNA target sequence. Thus,
the phosphorylation state of Rex in the infected cell may be a switch
that determines whether the virus exists in a latent or a productive
state. A mutational analysis of Rex-2 that focused on serine and
threonine residues was performed to identify regions or domains within
Rex-2 important for function, with a specific emphasis on identifying
Rex-2 phosphorylation mutants. We identified mutations near the carboxy
terminus that disrupted a novel region or domain and abrogated Rex-2
function. Mutant M17 (with S151A and S153A mutations) displayed reduced phosphorylation that correlated with reduced function. Replacement of
both serine residues 151 and 153 with phosphomimetic aspartic acid
restored Rex-2 function and locked Rex-2 in a phosphorylated active
conformation. A mutant containing threonine residues at positions 151 and 153 displayed a phenotype indistinguishable from that of wild-type
Rex. Furthermore, this same mutant showed increased threonine
phosphorylation and decreased serine phosphorylation, providing
conclusive evidence that one or both of these residues are
phosphorylated in vivo. Our results provide the first direct evidence
that the phosphorylation of Rex-2 is important for function. Further
understanding of HTLV Rex phosphorylation will provide insight into the
regulatory control of HTLV replication and ultimately the pathobiology
of HTLV.
 |
INTRODUCTION |
Human T-cell leukemia virus (HTLV)
types 1 (HTLV-1) and 2 (HTLV-2) are complex retroviruses that have been
causally associated with leukemia and neurological disorders in humans
(21). In addition to structural and enzymatic genes
gag, pol, and env, HTLV encodes two
trans-acting regulatory gene products, Tax and Rex, both of
which are essential for viral replication (15, 17, 24).
Tax acts to increase the rate of transcription from the viral long
terminal repeat (LTR). In addition, Tax modulates the transcription of
various cellular genes involved in growth and differentiation and
disrupts cell cycle control and DNA repair processes (3, 4, 38,
45, 47). These pleiotropic effects of Tax on cellular processes
are likely important in the ability of HTLV to mediate oncogenesis.
Consistent with this hypothesis, Tax was recently shown to be essential
for cellular transformation of primary human T lymphocytes in cultures
(39, 41).
Rex, the other trans-acting regulatory protein, specifically
binds unspliced and singly spliced viral RNAs, resulting in RNA stabilization and their selective trafficking to the cytoplasm (6, 30). These RNAs encode viral structural and enzymatic gene products. Rex function is mediated by a cis-acting RNA
sequence, termed the Rex-responsive element (RxRE), located in the R
region of the viral LTR (6, 9, 13, 20, 27, 35). Several functional domains of Rex have been identified to date. A highly basic
amino acid sequence at the amino terminus of HTLV-1 Rex (Rex-1) and
HTLV-2 Rex (Rex-2) is required for RNA binding and subcellular
targeting to the nucleus or nucleolus (25, 34, 43).
Both Rex-1 and Rex-2 have a leucine-rich activation domain that is
required for interaction with cellular factors, including the human
nucleoporin-like Rev/Rex activation domain binding protein (Rab) and
human Rev interactive protein (hRIP) cofactors involved in
nuclear export (18, 33). Recently, this activation domain was also shown to encompass a nuclear export signal (NES) and to be
indispensable for Rex function (37). Mutational and
chemical analyses of Rex-1 and the functionally analogous human
immunodeficiency virus (HIV) type 1 (HIV-1) Rev implicated a third
domain, responsible for multimerization of these proteins.
Although the exact nature of multimerization is debatable, it has been
suggested that multimerization is critical for Rex and HIV-1 Rev
function (12, 26, 31, 36).
Two forms of Rex-2, p24rex and
p26rex, are detected in HTLV-2-infected T cells
(40, 42). Both species of Rex-2 have also been detected in
cell lines transfected with rex expression plasmids; these
include 729 human B cells, SF9 insect cells, COS cells, and JM4 human T
cells (22-24, 40, 49). A previous study indicated that
p24rex and p26rex share
the same amino acid backbone and that they differ in the extent of
serine phosphorylation (23). Thus,
p26rex is the result of an altered conformation
induced by the phosphorylation of a subset of serine residues.
Similarly, Rex-1 is phosphorylated on serine, but phosphorylation does
not result in significant altered gel mobility (1).
Immunofluorescence studies have shown that
p24rex is present only in the cytoplasm, whereas
the phosphorylated form, p26rex, is
predominantly localized in the nucleus and nucleolus (16). Biochemical studies have indicated that the phosphorylated form of
Rex-2, p26rex, binds RxRE-containing RNA and
thus is biologically active (24). Interestingly, Tax has
been shown to be phosphorylated on a serine residue(s). One study
suggested that the phosphorylation of either serine 300 or serine 301 is required for localization to nuclear bodies and Tax-mediated
activation of gene expression (8). Another study
identified serine-to-alanine mutations important for Tax
transactivation function, but these serine residues were not
phosphorylated (11). The precise role of phosphorylation in the regulation of either Rex or Tax function has not yet been determined.
In this study, a mutational analysis of Rex-2 targeting serine and
threonine residues was performed to identify regions or domains within
Rex-2 important for function, with a specific emphasis on identifying
Rex-2 phosphorylation mutants. In addition to identifying mutations
that disrupt the RNA binding-nuclear localization domain, the
activation-effector-NES domain, and the multimerization domain, we
identified a novel region or domain at the carboxy terminus that is
important for Rex-2 function. One of the C-terminal mutants (with S151A
and S153A mutations [S151A,S153A]) displayed a reduction in
the p26 phosphorylated conformation of Rex that also correlated with
reduced Rex function. Replacement of both serine residues 151 and 153 with aspartic acid locked Rex-2 in a phosphorylated active state and
restored Rex-2 function. Two-dimensional (2D) phosphoamino acid
analysis of a Rex-2 mutant containing threonine residues at positions
151 and 153 revealed decreased serine phosphorylation in conjunction
with increased threonine phosphorylation, providing further evidence of
in vivo phosphorylation of these residues. Our data provide the first
direct evidence that the phosphorylation of critical residues at the
carboxy terminus of Rex-2 is critical for function. Further
understanding of HTLV Rex phosphorylation will provide insight into the
regulatory control of HTLV replication and ultimately HTLV pathogenesis.
 |
MATERIALS AND METHODS |
Cells.
293 T cells were maintained in Dulbecco modified
Eagle medium (DMEM) supplemented to contain 10% fetal calf
serum, penicillin (100 U/ml), streptomycin (100 µg/ml), and 2 mM glutamine.
Plasmids.
Rex expression vector BC20.2, containing HTLV-2
tax/rex cDNA expressed from the
cytomegalovirus (CMV) immediate-early gene promoter, has been described
earlier (14, 23). Various rex mutants were
generated by site-directed mutagenesis (with Quick Change; Stratagene)
using BC20.2 as a template. Mutations were confirmed by dideoxy DNA
sequencing. HIV-1 Tat expression vector pctat contains HIV-1
tat cDNA cloned downstream of the CMV promoter. Reporter
pCgagRxRE-II (a kind gift from Vincenzo Ciminale, University of Padua,
Padua, Italy) contains the HIV-1 LTR promoter and gag gene
linked to a 445-bp fragment of HTLV-2 spanning the RxRE (nucleotides 316 to 760 of the R-U5 region) (16). A CMV-luciferase
plasmid was used to control for transfection efficiency in each
experiment (luciferase assay system; Promega).
Transfection and p24gag enzyme-linked
immunosorbent assay.
Wild-type rex or various
rex mutant expression plasmids were introduced into 293 T
cells using the calcium phosphate transfection protocol. Briefly,
2 × 105 cells were transfected with 1 µg
of pctat, 3 µg of pCgagRxRE-II, 1 µg of CMV-luciferase plasmid, and
5 µg of wild-type rex or various rex mutant
expression plasmids or negative control. Cell lysates were made 48 h posttransfection using lysis buffer, containing 100 mM Tris (pH 7.6)
and 0.5% Triton X-100. Luciferase activity for each sample was
determined to control for transfection efficiency. HIV-1
p24gag levels in cell lysates were determined
using a p24gag enzyme-linked immunosorbent assay
(p24 HIV antigen assay kit; Beckman-Coulter).
p24gag calibration curves were generated using
HIV-1 p24 antigen standards as described by the kit
manufacturer; the detection sensitivity was 1 pg/ml. All the
experiments were performed in triplicate and normalized for
transfection efficiency. Statistical significance relative to results
for wild-type Rex was determined by the Student t test.
Metabolic labeling and immunoprecipitation.
Twenty-five
micrograms of wild-type rex or various rex mutant
expression plasmids or negative control was electroporated into 5 × 106 293 T cells (975 µF and 250 V). Cells
were metabolically labeled 24 h posttransfection with
[35S]methionine-[35S]cysteine
(Trans-35S-label, 100 mCi/ml; Amersham) in
methionine-cysteine-free RPMI 1640 supplemented with 20% dialyzed
fetal calf serum. Cells were lysed in immunoprecipitation buffer
(0.05 M Tris [pH 8.0], 0.1% sodium dodecyl sulfate [SDS], 1%
Triton X-100, 0.15 M NaCl, 2 mM phenylmethylsulfonyl fluoride, 1 µg
of leupeptin/ml, 1 µg of pepstatin A/ml), and the lysates were
clarified by centrifugation at 17,000 × g for 30 min
at 4°C. The lysates were subsequently immunoprecipitated using
anti-Rex antiserum (directed against C-terminal amino acid residues 139 to 170) for 16 h at 4°C. Protein A-Sepharose CL-4B (Sigma) was
used to collect the immune complexes. Proteins were directly
electrophoresed on an SDS-10% polyacrylamide gel;
alternatively, for in vitro dephosphorylation experiments, prior to
electrophoresis the immune complexes were incubated with 600 U of
bacterial alkaline phosphatase (BAP) (GIBCO BRL) for 3 h at 65°C
in 50 µl of BAP buffer, containing 50 mM NaCl, 10 mM Tris-Cl (pH
8.0), and 10 mM MgCl2.
35S-labeled proteins were visualized by
autoradiography and quantified by PhosphorImager analysis (Molecular Dynamics).
2D phosphoamino acid analysis.
293 T cells (5 × 106) were electroporated with 25 µg of
wild-type rex expression plasmid BC20.2 or rex
mutant S151T,S153T at 975 µF and 250 V. At 24 h
posttransfection, cells were metabolically labeled with 2 mCi of
32Pi/ml, and cell lysates
were prepared as described above. p26rex
phosphorylated in vivo was resolved on an SDS-10% polyacrylamide gel,
transferred to an Immobilon-P membrane (Millipore), and detected by
autoradiography. Samples were prepared and 2D phosphoamino acid
analysis was performed as previously described. Briefly, membrane
pieces containing phosphorylated p26rex
were incubated in 0.5% polyvinylpyrrolidone in 100 mM acetic acid for
30 min at 37°C. The membrane was then washed three times in
H2O and subjected to hydrolysis using 5.7 M HCl
at 110°C for 60 min. The supernatant containing the hydrolyzed amino
acids was centrifuged at 17,000 × g for 10 min, washed
by repeated lyophilization, and subjected to 2D phosphoamino acid
analysis using a thin-layer electrophoresis system (HTLE-7000; CBS
Scientific, Del Mar, Calif.). The hydrolyzed amino acids were applied
to thin-layer cellulose plates along with phosphorylated Ser
(p-Ser), p-Thr, and a p-Tyr standards at 0.5 µg each per
µl; electrophoresed at pH 1.9 for 25 min at 1.0 kV (~13 mA)
in the first dimension; and then subjected to electrophoresis in the
second dimension at pH 3.5 for 20 min at 1.5 V (~16 mA). Amino acid
standards were visualized by staining with 0.25% ninhydrin in acetone,
and the radiolabeled amino acids were visualized by direct
autoradiography and quantified by PhosphorImager analysis.
 |
RESULTS |
Generation of Rex-2 mutants.
The phosphorylation of Rex-2
primarily on serine residues has been shown to be critical for
functional RNA binding (23, 24). The 170-amino-acid Rex-2
protein contains 25 serine and 12 threonine residues that are potential
phosphorylation sites. Our objective was to introduce mutations
throughout the wild-type rex-2 expression plasmid, BC20.2,
which would cause the substitution of alanine for serine or threonine
residues. Based on previous reports and on alignment with Rex-1,
several of our mutations were predicted to occur in the RNA binding
region or nuclear localization domain (amino acids 1 to 19),
activation-effector domain containing the overlapping NES (amino acids
81 to 94), and multimerization domain (amino acids 57 to 66 and 106 to
124). In all, 19 Rex-2 mutants were generated consisting of 6 single
amino acid substitutions, 9 double amino acid substitutions, and 4 triple amino acid changes. Figure 1A
shows the alignment of Rex-1 and Rex-2 and the previously identified
domains. Figure 1B shows the predicted amino acid substitutions in our
panel of mutants.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Amino acid alignment of Rex-1 (top) and Rex-2
(bottom). Identities are indicated by double dots, and similarities are
indicated by single dots. Rex-2 is 19 amino acid residues shorter than
Rex-1. Rex-1 domains, including the nuclear localization (NLS)-RNA
binding (25, 34, 43), multimerization, and
activation-effector domains, are indicated (12, 25, 31, 34,
43). The locations of the Rex-2 mutants are indicated. (B)
Summary of all mutations (M1 to M19).
|
|
Expression of Rex-2 mutants.
The stable expression of the
various Rex-2 mutants from metabolically labeled 293 T cells was
determined by radioimmunoprecipitation and SDS-polyacrylamide gel
electrophoresis (PAGE) using anti-Rex-2 peptide antiserum. As expected,
in cells transfected with our wild-type rex-2 expression
construct, the p24rex form and the
phosphorylated p26rex conformation were detected
(Fig. 2). All of the Rex-2 mutants appeared to be stably expressed. With the exception of M9, all of the
mutants displayed both forms of the Rex protein. To determine if there
were significant differences in the levels of
p26rex and p24rex, we
quantitated their amounts over four independent experiments; the
results are summarized as an average
p26rex/p24rex ratio below
each lane of Fig. 2. The majority of the mutants displayed ratios
similar to that of wild-type Rex (a
p26rex/p24rex ratio of
nearly 1). Interestingly, a mutant with a mutation at the carboxy
terminus, M17 (S151A,S153A), showed a significant reduction in the
amount of p26rex in multiple experiments, with
an average p26rex/p24rex
ratio of 0.54 (Fig. 2, lane M17; see also Fig. 4 and 7B). These results
suggest that residues 151 and/or 153 might be important for protein
modification and/or conformation.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Detection of Rex-2 mutants in 293 T cells. 293 T cells
were transfected with 25 µg of wild-type (Wt) or various
rex mutant expression vectors or vector alone (control).
At 24 h posttransfection, cells were metabolically labeled using
[35S]methionine-[35S]cysteine; cell lysates
were made as described in Materials and Methods. Lysates were
immunoprecipitated using anti-Rex antiserum in the presence of protein
A-Sepharose. Immunoprecipitated proteins were fractionated by SDS-PAGE
and visualized by autoradiography. 14C low-molecular-mass
markers are indicated on the left (lane M). The results indicate that
all of the Rex mutants are efficiently expressed in 293 T cells.
p26rex and p24rex were
quantitated by PhosphorImager analysis over four independent
experiments, and values were averaged. The
p26rex/p24rex ratio is
presented below each lane. (Note that M17 displays a significant
reproducible reduction in the level of
p26rex.)
|
|
Rex-2 mutants segregate into four functional regions or
domains.
Our series of Rex-2 mutants were tested for their ability
to function in a quantitative bioassay using reporter plasmid
pCgagRxRE-II. This plasmid contains the HIV-1 LTR and gag
gene linked to the RxRE of HTLV-2 and the simian virus 40 polyadenylation signal or site (16). Efficient expression
of Gag is dependent on Tat-mediated transcription and functional Rex
binding to RxRE sequences. 293 T cells were cotransfected with pctat,
pCgagRxRE-II, and wild-type or mutant rex expression vectors
or negative control, and p24gag production was
monitored using a Gag antigen capture assay. To test the sensitivity of
this system, we performed a titration with increasing concentrations of
rex expression plasmid, keeping the concentrations of pctat
and pCgagRxRE II constant. We did not see any significant difference in
p24gag values at concentrations between 1 and 5 µg of rex plasmid (data not shown). Therefore, all the
subsequent experiments were performed with 5 µg of rex
expression plasmid (saturating concentration of rex
expression plasmid).
Our analysis revealed functionally deficient Rex-2 mutants
clustering in four regions or domains (Fig.
3). Mutant M1, with mutations within the
amino-terminal RNA binding-nuclear localization domain, showed
p24gag levels 50% those in our reporter assay.
Mutants M9 and M10, with mutations within the effector-activation
domain (also containing the overlapping NES), showed drastic reductions
in p24gag production compared to wild-type
Rex-2. Previous studies have shown that the activation domain or
effector domain is required for various protein-protein interactions
and is indispensable for Rex-1 and Rex-2 function (18,
37). Mutants M5 and M14 exhibited significant reductions in
p24gag levels compared to wild-type Rex-2. Amino
acid alignment of Rex-1 and Rex-2 suggested that these mutations are
within the multimerization domain identified for Rex-1. Previous work
has suggested that multimerization is required for Rex-1 function
(12, 48). Therefore, it would appear that a similar domain
is present in Rex-2 and that multimerization is required for function.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
Rex-2 functional assay. 293 T cells (2 × 105) were transfected with 1 µg of pctat, 3 µg of
pCgagRxRE-II, 1 µg of luciferase, and 5 µg of wild-type (Wt) or
various rex mutant expression vectors or vector alone
(C). At 48 h posttransfection, cells were harvested and assayed
for p24gag as described in Materials and
Methods. Lysates were assayed for luciferase activity to control for
transfection efficiency. The values, which represent relative
p24gag levels for three independent experiments,
are normalized to the value for Wt rex (set as 1). Error
bars indicate standard deviations. Significance relative to the
results for Wt Rex was determined by the Student t test;
values that are statistically different are indicated by asterisks. The
data suggest that functionally deficient Rex-2 mutants segregate into
four groups.
|
|
M16, M17, M18, and M19, containing carboxy-terminal mutations,
displayed approximately 25 to 40% the activity of wild-type Rex. The
majority of functionally deficient mutants had
p26rex/p24rex ratios
similar to that of wild-type Rex, with the exception of M17. Although
our results suggest a novel functional domain located at the carboxy
terminus, we focused the remainder of our study on residues 151 and 153 because the reduction in M17 activity or function correlated with
altered mobility or, more specifically, a reduction in the amount of
phosphorylated p26rex.
Phosphomimetic substitutions at serine 151 and serine 153 lock Rex
in a p26 functional state.
To test the hypothesis that serines 151 and 153 are residues that are phosphorylated and critical for function,
the serine residues were mutated either individually or in combination
to alanine and/or aspartic acid to mimic phosphoserine. We first investigated the expression and mobility of these mutants by SDS-PAGE. Interestingly, aspartic acid residues at positions 151 and/or 153 migrated as a single 26-kDa band (p26rex) with
no detectable p24rex (Fig.
4). This result indicates that the
replacement of serine at position 151 or 153 by aspartic acid appears
to lock the protein in a phosphorylated state or conformation. We next
tested the aspartic acid mutants in the Rex functional reporter assay.
The results indicate that all three aspartic acid mutants are fully functional (Fig. 5). Together, these
results further support the notion that the phosphorylated
p26rex conformation is the active form of Rex
and suggest that modification of residues 151 and/or 153 contributes to
this conformation and activity.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 4.
Detection of Rex-2 phosphorylation mutants in 293 T
cells. Transfection, immunoprecipitation, and SDS-PAGE analysis were
performed as described in the legend to Fig. 2. Wild-type (Wt)
Rex, various Rex mutants, and the control are indicated. The data
indicate that serines 151 and 153 are required for the
phosphorylation-induced mobility shift from
p24rex to p26rex and that
replacement of either one or both serines 151 and 153 with aspartic
acid locks the protein in a phosphorylated conformation. Lane M,
markers.
|
|

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 5.
Rex-2 functional assay for phosphorylation mutants. The
Rex functional assay was performed as described in the legend to Fig.
3. Wild-type (Wt) Rex, various Rex mutants, and the control are
indicated. Error bars indicate standard deviations. Significance
relative to the results for Wt Rex was determined by the Student
t test; a value that is statistically different is
indicated by an asterisk. The results suggest that serines 151 and 153 are necessary for function and that replacement of these sites
with a phosphomimetic amino acid restores the activity to Wt
levels.
|
|
If the level of p26rex correlates with function,
then one might expect that since the aspartic acid mutants with
mutations at positions 151 and/or 153 are found exclusively in the
phosphorylated p26rex active conformation, these
mutants should show higher levels of functional activity than wild-type
Rex. To test this hypothesis, the activities of wild-type Rex
and the M17 (S151A,S153A) and S151D,S153D double mutants were assessed
by use of the Gag reporter assay with increasing DNA concentrations of
wild-type and rex mutant plasmids. Our results indicate that
the activity of M17 (S151A,S153A) is approximately 25 to 30% that of
wild-type Rex over a range of rex expression plasmid
concentrations (0.1 to 5 µg), whereas S151D,S153D is significantly
more active at the lowest concentration tested; this difference is
gradually lost and disappears at higher concentrations (Fig.
6). Taken together, these results are
consistent with the conclusion that the phosphorylation of serines 151 and/or 153 of Rex-2 results in a hyperphosphorylated and biologically
functional Rex protein (p26rex).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 6.
The S151D,S153D mutant is more active than wild-type
Rex. 293 T cells (2 × 105) were transfected with 1 µg of pctat, 3 µg of pCgagRxRE-II, 1 µg of luciferase, and
increasing concentrations (0.1 to 5 µg) of wild-type (WT) or
rex mutant (M17 [S151A,S153A] or S151D,S153D)
expression vectors. At 48 h posttransfection, cells were harvested
and assayed for p24gag as described in Materials
and Methods. Lysates were assayed for luciferase activity to control
for transfection efficiency. The values represent actual
p24gag levels for three independent experiments.
Error bars indicate standard deviations. The results indicate
that at lower DNA concentrations, Rex mutant S151D,S153D (exclusively
in the p26rex conformation) is significantly
more active than WT Rex.
|
|
We next determined whether phosphorylation at some other site was
responsible or required for maintaining the aspartic acid mutant with
mutations at positions 151 and 153 exclusively in the
p26rex conformation. The S151D,S153D mutant
protein was subjected to BAP treatment in vitro. As previously reported
(24), BAP treatment of wild-type Rex-2 resulted in the
loss of p26rex and a concomitant increase in the
amount of p24rex (Fig.
7A). However, BAP treatment had no effect
on the mobility of the S151D,S153D p26rex mutant
(Fig. 7A). These results provide further evidence that phosphomimetic
aspartic acid at positions 151 and 153 locks the protein in a
phosphorylated active conformation. Similar analysis of the M17 mutant
(S151A,S153A) indicated that the reduced or remaining amount of
p26rex was subject to loss following BAP
treatment (Fig. 7B). These results indicate that the phosphorylation of
an additional site(s) leads to the conformational change and further
suggest that the phosphorylation of residues 151 and/or 153 likely
stabilizes that conformation.

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 7.
In vitro dephosphorylation of wild-type Rex-2, the
S151D,S153D mutant, and mutant M17. (A) 293 T cells were transfected
with 25 µg of wild-type (Wt) or rex mutant
(S151D,S153D) expression vector. At 24 h posttransfection, cells
were metabolically labeled using
[35S]methionine-[35S]cysteine, and cell
lysates were made as described in Materials and Methods. Transfected
cell lysates were immunoprecipitated using anti-Rex-antiserum. Immune
complexes were collected using protein A-Sepharose and incubated with
600 U of BAP for 3 h or mock treated, and the proteins were
resolved by SDS-PAGE and visualized by autoradiography. 14C
low-molecular-mass markers are indicated on the left (lane M). The
results indicate that the phosphorylation-induced change in mobility on
the SDS gel is due to the presence of aspartic acid residues at
positions 151 and 153. (B) An experiment was performed as described for
panel A to compare Wt Rex to mutant M17. The results indicate that the
p26rex conformation of mutant M17 is the
result of phosphorylation.
|
|
To investigate the individual contributions of serines 151 and 153 to
the phosphorylation-induced conformational change and Rex-2 function,
we made single amino acid changes at either position 151 or position153
by mutating the amino acid to either alanine or aspartic acid. SDS gel
analysis of the S151A mutant shows a predominant
p24rex form and a reduced
p26rex form, similar to the results obtained
with the alanine double mutant M17. The S153A mutant shows equal levels
of p24rex and p26rex,
similar to those seen with wild-type Rex (Fig.
8). These results suggest that serine 151 plays a greater role than serine 153 in the phosphorylation-induced
mobility change on the SDS gel. Functional analyses of these mutants
are consistent with the level of p26rex. S151A
shows a significant reduction in activity, whereas S153A function is
similar to that of wild-type Rex (Fig.
9). Interestingly, replacement of either
serine 151 or serine 153 with aspartic acid is capable of locking the
protein in a phosphorylated state, as measured by decreased mobility
(Fig. 8). BAP treatment of both the S151D and the S153D mutants did not
result in the loss of p26rex (data not shown).
In addition, double mutants (S151A,S153D and S151D,S153A) are fully
functional and migrate as a single p26rex
species (Fig. 4 and 5). Taken together, these data indicate that aspartic acid at either or both residues 151 and 153 is sufficient to
lock the protein in the p26rex conformation,
consistent with a phosphorylated state. However, when tested alone,
residue 151 appears to play a more significant role.

View larger version (62K):
[in this window]
[in a new window]
|
FIG. 8.
Detection of single phosphorylation mutants with
mutations at residues 151 and 153 in 293 T cells. Transfection,
immunoprecipitation, and SDS-PAGE analysis were performed as described
in the legend to Fig. 1. The various Rex mutants analyzed are
indicated. The data suggest that serine 151 is more important than
serine 153 for the phosphorylation-induced mobility shift from
p24rex to p26rex.
|
|

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 9.
Rex-2 functional assay for single phosphorylation
mutants with mutations at residues 151 and 153. The methods used are
described in the legend to Fig. 3. Wild-type (Wt) Rex and the various
Rex mutants analyzed are indicated. Error bars indicate standard
deviations. Significance relative to the results for Wt Rex was
determined by the Student t test; a value that is
statistically different is indicated by an asterisk.The results
suggest that serine 151 is more important than serine 153 in Rex
function.
|
|
Serine 151 and serine 153 are critical phosphorylation sites.
We next directly evaluated whether residues 151 and 153 are truly
phosphorylated in vivo. Earlier studies had shown that Rex-2 is
phosphorylated predominantly on serine residues (23).
Therefore, if these residues are phosphorylated, replacement of serines
151 and 153 with threonine should result in increased threonine
phosphorylation in conjunction with decreased serine phosphorylation.
SDS gel and functional analyses of the S151T,S153T mutant revealed that its mobility and functional activity are similar to those of wild-type Rex-2, suggesting that threonine at these residues can efficiently substitute for serine (data not shown).
We next performed 2D phosphoamino acid analysis of the S151T,S153T
mutant and wild-type Rex. We found a clear increase in threonine
phosphorylation (Fig. 10).
PhosphorImager analysis indicates that this increased threonine
phosphorylation in the S151T,S153T mutant coincides with a 70%
reduction in serine phosphorylation compared to the results for
wild-type Rex. This finding provides direct evidence that residues 151 and/or 153 are phosphorylated in vivo. Interestingly, the S151T,S153T
mutant still retained some serine phosphorylation, indicating that
there is an additional serine(s) phosphorylated on Rex-2. This finding
is consistent with the results of the BAP experiments shown in Fig. 7B,
in which M17 still contained phosphorylated residues that contributed
to the p24rex-to-p26rex
conformational change. However, mutation of serine residues 151 and/or
153, either preventing phosphorylation or mimicking phosphoserine, has
a direct effect on Rex-2 mobility or conformation and function.

View larger version (37K):
[in this window]
[in a new window]
|
FIG. 10.
2D phosphoamino acid analysis for the wild type and
threonine mutants. 293 T cells were transfected with 25 µg of
wild-type Rex or the Rex threonine mutant. At 24 h
posttransfection, cells were metabolically labeled using 2 mCi of
[32Pi], and cell lysates were made as
described in Materials and Methods. Transfected cell lysates were
immunoprecipitated using anti-Rex antiserum, and proteins were
transferred to an Immobilon-P membrane. The band corresponding to
p26rex was cut out of the membrane and digested
with 5.7 M HCl. 2D phosphoamino acid analysis was done on thin-layer
cellulose plates in the first dimension at pH 1.9 followed by
the second dimension perpendicular to the first at pH 3.4 as indicated
in Materials and Methods. The data indicate that residues 151 and/or
153 are phosphorylated in vivo.
|
|
 |
DISCUSSION |
It was previously demonstrated that phosphorylation of
HTLV-2 Rex is required for efficient binding to viral target RNAs
containing the RxRE (24). In this study, we subjected
HTLV-2 Rex to mutational analysis to identify functional domains, with
specific emphasis on identifying Rex-2 phosphorylation mutants. We
identified four distinct groups of functionally deficient Rex-2
mutants. In addition to identifying mutants that disrupt the RNA
binding-nuclear localization domain, the activation-effector domain
(also containing the overlapping NES), and the multimerization domain,
we identified a novel region or domain at the carboxy terminus that
disrupts Rex-2 function. One carboxy-terminal mutant (S151A,S153A)
displayed reduced phosphorylation that correlated with reduced
function. Our further analysis indicated that serine residues 151 and/or 153 are phosphorylated in vivo and that this phosphorylation is
likely critical to maintain Rex-2 in an active conformation required
for efficient function.
It has been well documented that posttranslational modification of
proteins by phosphorylation affects protein conformation and/or
function. For example, a mobility change detected by SDS-PAGE analysis
of the fos nuclear oncoprotein (7),
polyomavirus large T antigen (10), and adenovirus E1A
(44) results from phosphorylation on one or more serine
residues. It has been hypothesized that this mobility shift is likely
due to a change in protein structure which might be critical for
protein function. Interestingly, a recent study investigating the
signaling protein nitrogen regulatory protein C (NtrC) revealed that
activation by phosphorylation involved stabilization of a preexisting
condition or conformation. Nuclear magnetic resonance measurements
indicated that phosphorylation shifted the equilibrium of NtrC far
toward the active conformation (46).
A previous study indicated that p26rex is a
phosphorylated form of p24rex and that
phosphorylation on serine residues is critical for its ability to
specifically bind RxRE-containing RNA (24). In addition, it has been shown that the phosphorylated form of Rex-2 is required to
inhibit RNA splicing reactions in vitro (5). Thus, the
p26rex phosphorylated form is the active form
which would be required for HTLV to be in the productive phase of viral
replication. In HTLV-infected cells, both phosphorylated and
nonphosphorylated forms of Rex are present. We speculate that the
concentration of phosphorylated Rex is dependent on environmental
stimuli and the balance of highly regulated cellular kinase and
phosphatase activities.
We propose a model for the role of phosphorylation and function of
Rex-2 consistent with the current literature and our experimental data
(Fig. 11). The initial Rex translation
product, p24rex, found only in the cytoplasm, is
phosphorylated at a currently unidentified serine(s), resulting in an
active p26rex unstable intermediate. Several
lines of evidence indicate that Rex is phosphorylated on at least one
residue in addition to serines 151 and/or 153. First, tryptic digestion
of in vivo 32Pi-labeled
p26rex revealed multiple
32Pi-incorporating
peptides (24). However, the functional relevance of these
phosphorylation sites has not been elucidated. Second, in this report
we show by 2D phosphoamino acid analysis that the threonine mutant
(S151T,S153T) still contains significant levels of serine
phosphorylation. Last, a reduced amount of
p26rex is still detected in the S151A,S153A
mutant and shows 30 to 40% the functional activity of wild-type
Rex. We propose that the p26rex
intermediate is unstable and is subject to dephosphorylation (returning
to the p24rex conformation) or subsequent
phosphorylation at serines 151 and/or 153, which is required for the
optimal function of Rex-2. This further phosphorylation at residues 151 and/or 153 may stabilize the p26rex
conformation, possibly rendering it more resistant to phosphatases and
dephosphorylation. Alanine substitutions at positions 151 and/or 153 (reduced p26rex) likely result in the
destabilization of p26rex, since it cannot be
further phosphorylated and thus is more sensitive to dephosphorylation,
pushing the equilibrium toward the inactive p24rex form. The replacement of serines 151 and/or 153 with phosphomimetic aspartic acid locks the protein in the
p26rex conformation, consistent with an
irreversible equilibrium shift toward the stable and active
p26rex form. Thus far, we have not been able to
identify another phosphorylation site(s) critical for function.
However, one possible candidate is serine 88. Our results indicate that
mutant M9 (S88A,T90A) is nonfunctional and migrates as a single
unphosphorylated protein (Fig. 2, lane M9, and data not shown).

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 11.
Model for Rex-2 phosphorylation and function.
p24rex is the primary Rex-2 translation product
that is initially phosphorylated on an as-yet-unidentified serine(s),
resulting in an unstable, but functional p26rex
intermediate. This intermediate can now be subsequently phosphorylated
on serines 151 and/or 153, resulting in a functional, stable
p26rex form.
|
|
There are several reports investigating the role of phosphorylation in
the function of the HTLV Rex protein or the functionally analogous HIV
Rev protein. Recently, Fouts et al. demonstrated that phosphorylation
is required for recombinant HIV-1 Rev protein to enter rapidly into an
efficient RNA binding state (19). The investigators also
mapped the phosphorylation sites (Ser-54 and Ser-56) to be within the
multimerization domain and showed that phosphorylation does not
affect multimerization (19). Interestingly, this
phosphorylation sequence is not conserved in the less pathogenic HIV-2.
Studies of HTLV-1 Rex phosphorylation have revealed three phosphorylation sites, corresponding to Ser-70, Thr-174, and Ser-177 (1). Again, detailed functional studies of mutants to test the biological significance of phosphorylation and Rex function have
not been performed. However, treatment of HTLV-1-infected T cells with
protein kinase inhibitor H-7 results in a decreased level of
Rex-regulated viral unspliced gag-pol mRNA,
corresponding to reduced in vivo phosphorylation of Rex, suggesting a
role for protein kinase C (2).
Amino acid sequence analysis of Rex-2 reveals that serine 151 falls in
a predicted consensus site for phosphorylation by casein kinase 1, Sp/Tp-X2-3-S/T-X
(28, 29). HIV-1 Rev has recently been shown to be
phosphorylated on Ser-5 and Ser-8 both in vitro and in vivo by casein
kinase 2, and this phosphorylation is important for its function
(32). Thus, identification of cellular kinases phosphorylating Rex-2 will be critical to understanding the control of
Rex activity in the HTLV life cycle and may identify distinct differences between HTLV-1 and HTLV-2.
In conclusion, our data provide the first direct evidence that
phosphorylation is critical for the function of Rex-2. One implication
of this finding is that HTLV-2 gene expression is regulated at the
cellular level. A virus such as HTLV that encodes its own regulatory
genes would be better able to adapt if it could respond to regulatory
signals of the cells it infects. Therefore, the dependence of Rex
function on phosphorylation provides an additional level of replication
control and might better allow the virus to escape the immune pressures
of the infected host.
We thank Kathleen Boris-Lawrie and Michael Lairmore for critical
comments. We also thank Tim Vojt for preparation of the figures.
| 1.
|
Adachi, Y.,
T. D. Copeland,
C. Takahashi,
T. Nosaka,
A. Ahmed,
S. Oroszlan, and M. Hatanaka.
1992.
Phosphorylation of the Rex protein of human T-cell leukemia virus type I.
J. Biol. Chem.
267:21977-21981[Abstract/Free Full Text].
|
| 2.
|
Adachi, Y.,
T. Nosaka, and M. Hatanaka.
1990.
Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I (HTLV-II).
Biochem. Biophys. Res. Commun.
169:469-475[CrossRef][Medline].
|
| 3.
|
Akagi, T.,
H. Ono, and K. Shimotohno.
1996.
Expression of cell-cycle regulatory genes in HTLV-I infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4, and p21Waf1/Cip1/Sdi1.
Oncogene
12:1645-1652[Medline].
|
| 4.
|
Armstrong, A. P.,
A. A. Franklin,
M. N. Henbogaard,
H. A. Giebler, and J. K. Nyborg.
1993.
Pleiotropic effect of the human T-cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors.
Proc. Natl. Acad. Sci. USA
90:7303-7307[Abstract/Free Full Text].
|
| 5.
|
Bakker, A. L. X.,
C. T. Ruland,
D. W. Stephens,
A. C. Black, and J. D. Rosenblatt.
1996.
Human T-cell leukemia virus type 2 Rex inhibits pre-mRNA splicing in vitro at an early stage of spliceosome formation.
J. Virol.
70:5511-5518[Abstract/Free Full Text].
|
| 6.
|
Ballaun, C.,
G. R. Farrington,
M. Dobrovnik,
J. Rusche,
J. Hauber, and E. Bohnlein.
1991.
Functional analysis of human T-cell leukemia virus type I Rex-response element: direct RNA binding of Rex protein correlates with in vivo binding activity.
J. Virol.
65:4408-4413[Abstract/Free Full Text].
|
| 7.
|
Barber, J. R., and I. M. Verma.
1987.
Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum.
Mol. Cell. Biol.
7:2201-2211[Abstract/Free Full Text].
|
| 8.
|
Bex, F.,
K. Murphy,
R. Wattiez,
A. Burny, and R. B. Gaynor.
1999.
Phosphorylation of the human T-cell leukemia virus type 1 transactivator Tax on adjacent serine residues is critical for Tax activation.
J. Virol.
73:738-745[Abstract/Free Full Text].
|
| 9.
|
Black, A.,
I. S. Chen,
S. Arrigo,
C. T. Ruland,
T. Allogiamento,
E. Chin, and J. D. Rosenblatt.
1991.
Regulation of HTLV-II gene expression by Rex involves positive and negative cis-acting elements in the 5' long terminal repeat.
Virology
181:433-444[CrossRef][Medline].
|
| 10.
|
Bockus, B. J., and B. Schaffhausen.
1987.
Phosphorylation of polyomavirus large T antigen: effects of viral mutations and cell growth state.
J. Virol.
61:1147-1154[Abstract/Free Full Text].
|
| 11.
|
Boehm, A. K.,
J. A. Stawhecher,
O. J. Semmes,
P. E. Jankowski,
R. Lewis, and S. H. Hinrichs.
1999.
Analysis of potential phophorylation sites in human T cell leukemia virus type 1 Tax.
J. Biomed. Sci.
6:206-212[Medline].
|
| 12.
|
Bogerd, H., and W. C. Greene.
1993.
Dominant negative mutants of human T-cell leukemia virus type I Rex and human immunodeficiency virus type 1 Rev fail to multimerize in vivo.
J. Virol.
67:2496-2502[Abstract/Free Full Text].
|
| 13.
|
Bogerd, H. P.,
L. S. Tiley, and B. R. Cullen.
1992.
Specific binding of the human T-cell leukemia virus type I Rex protein to a short RNA sequence located within the Rex-response element.
J. Virol.
66:7572-7575[Abstract/Free Full Text].
|
| 14.
|
Cann, A. J.,
Y. Koyanagi, and I. S. Y. Chen.
1988.
High efficiency transfection of primary human lymphocytes and studies of gene expression.
Oncogene
3:123-128.
|
| 15.
|
Chen, I. S. Y.,
D. J. Slamon,
J. D. Rosenblatt,
N. P. Shah,
S. G. Quan, and W. Wachsman.
1985.
The x gene is essential for HTLV replication.
Science
229:54-58[Abstract/Free Full Text].
|
| 16.
|
Ciminale, V.,
L. Zotti,
D. M. D'Agostino, and L. Chieco-Bianchi.
1997.
Inhibition of human T-cell leukemia virus type 2 Rex function by truncated forms of Rex encoded in alternatively spliced mRNAs.
J. Virol.
71:2810-2818[Abstract].
|
| 17.
|
Cullen, B. R.
1992.
Mechanism of action of regulatory proteins encoded by complex retroviruses.
Microbiol. Rev.
56:375-394[Abstract/Free Full Text].
|
| 18.
|
Elfgang, C.,
O. Rosorius,
L. Hofer,
H. Jaksche,
J. Hauber, and D. Bevec.
1999.
Evidence for specific nucleocytoplasmic transport pathways used by leucine-rich nuclear export signals.
Proc. Natl. Acad. Sci. USA
96:6229-6234[Abstract/Free Full Text].
|
| 19.
|
Fouts, D. E.,
H. L. True,
K. A. Cengel, and D. W. Celander.
1997.
Site-specific phosphorylation of the human immunodeficiency virus type-1 Rev protein accelerates formation of an efficient RNA-binding conformation.
Biochemistry
36:13256-13262[CrossRef][Medline].
|
| 20.
|
Grassmann, R.,
S. Berchtolds,
C. Aepinus,
C. Ballaun,
E. Bohnlein, and B. Fleckenstein.
1991.
In vitro binding of human T-cell leukemia virus Rex proteins to the Rex-response element of viral transcripts.
J. Virol.
65:3721-3727[Abstract/Free Full Text].
|
| 21.
|
Green, P. L., and I. S. Y. Chen.
1994.
Molecular features of the human T-cell leukemia virus: mechanisms of transformation and leukemogenicity, p. 227-311.
In
J. A. Levy (ed.), The Retroviridae, vol. 3. Plenum Press, New York, N.Y.
|
| 22.
|
Green, P. L.,
Y. Xie, and I. S. Y. Chen.
1990.
The internal methionine codons of the human T-cell leukemia virus type II rex gene are not required for p24rex production or virus replication and transformation.
J. Virol.
64:4914-4921[Abstract/Free Full Text].
|
| 23.
|
Green, P. L.,
Y. Xie, and I. S. Y. Chen.
1991.
The Rex proteins of human T-cell leukemia virus type II differ by serine phosphorylation.
J. Virol.
65:546-550[Abstract/Free Full Text].
|
| 24.
|
Green, P. L.,
M. T. Yip,
Y. Xie, and I. S. Y. Chen.
1992.
Phosphorylation regulates RNA binding by the human T-cell leukemia virus Rex protein.
J. Virol.
66:4325-4330[Abstract/Free Full Text].
|
| 25.
|
Hammes, S. R., and W. C. Greene.
1993.
Multiple arginine residues within the basic domain of HTLV-I Rex are required for specific RNA binding and function.
Virology
193:41-49[CrossRef][Medline].
|
| 26.
|
Hataka, Y.,
T. Umemoto,
S. Matsushita, and H. Shida.
1998.
Involvement of human CRM1 (exportin 1) in the export and multimerization of the Rex protein of human T-cell leukemia virus type 1.
J. Virol.
72:6602-6607[Abstract/Free Full Text].
|
| 27.
|
Kim, J. H.,
P. A. Kaufman,
S. M. Hanly,
L. T. Rimsky, and W. C. Greene.
1991.
Rex transregulation of human T-cell leukemia virus type II gene expression.
J. Virol.
65:405-414[Abstract/Free Full Text].
|
| 28.
|
Kreegipuu, A.,
N. Blom, and S. Brunak.
1999.
PhosphoBase, a database of phosphorylation sites: release 2.0.
Nucleic Acids Res.
27:237-239[Abstract/Free Full Text].
|
| 29.
|
Kreegipuu, A.,
N. Blom,
S. Brunak, and J. Jarv.
1998.
Statistical analysis of protein kinase specificity determinants.
FEBS Lett.
430:45-50[CrossRef][Medline].
|
| 30.
|
Kusuhara, K.,
M. Anderson,
S. M. Pettiford, and P. L. Green.
1999.
Human T-cell leukemia virus type 2 Rex protein increases stability and promotes nuclear to cytoplasmic transport of gag/pol and env RNAs.
J. Virol.
73:8112-8119[Abstract/Free Full Text].
|
| 31.
|
Madore, S. J.,
L. S. Tiley,
M. H. Malim, and B. R. Cullen.
1994.
Sequence requirements for Rev multimerization in vivo.
Virology
202:186-194[CrossRef][Medline].
|
| 32.
|
Marin, O.,
S. Sarno,
M. Boschetti,
M. A. Pagano,
F. Meggio,
V. Ciminale,
D. M. D'Agostino, and L. A. Pinna.
2000.
Unique features of HIV-1 Rev protein phosphorylation by protein kinase CK2 (`casein kinase-2')
FEBS Lett.
481:63-67[CrossRef][Medline].
|
| 33.
|
Michael, W. M.,
M. Choi, and G. Dreyfuss.
1995.
A nuclear export signal in hnRNP A1: a signal-mediated, temperature-dependent nuclear protein export pathway.
Cell
83:415-422[CrossRef][Medline].
|
| 34.
|
Nosaka, T.,
H. Siomi,
Y. Adachi,
M. Ishibashi,
S. Kubota,
M. Maki, and M. Hatanaka.
1989.
Nucleolar targeting signal of human T-cell leukemia virus type I Rex-encoded protein is essential for cytoplasmic accumulation of unspliced viral mRNA.
Proc. Natl. Acad. Sci. USA
86:9798-9802[Abstract/Free Full Text].
|
| 35.
|
Ohta, M.,
H. Nyunoya,
H. Tanaka,
T. Okamoto,
T. Akagi, and K. Shimotohno.
1988.
Identification of a cis-regulatory element involved in accumulation of human T-cell leukemia virus type II genomic mRNA.
J. Virol.
62:4445-4451[Abstract/Free Full Text].
|
| 36.
|
Olsen, H. S.,
A. W. Cochrane,
P. J. Dillon,
C. M. Nalin, and C. A. Rosen.
1990.
Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids.
Genes Dev.
4:1357-1364[Abstract/Free Full Text].
|
| 37.
|
Palmeri, D., and M. H. Malim.
1996.
The human T-cell leukemia virus type 1 posttranscriptional trans-activator Rex contains a nuclear export signal.
J. Virol.
70:6442-6445[Abstract].
|
| 38.
|
Ressler, S.,
G. F. Morris, and S. J. Marriott.
1997.
Human T-cell leukemia virus type 1 Tax transactivates the human proliferating cell nuclear antigen promoter.
J. Virol.
71:1181-1190[Abstract].
|
| 39.
|
Robek, M. D., and L. Ratner.
1999.
Immortalization of CD4+ and CD8+ T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone.
J. Virol.
73:4856-4865[Abstract/Free Full Text].
|
| 40.
|
Rosenblatt, J. D.,
A. J. Cann,
D. J. Slamon,
I. S. Smalberg,
N. P. Shah,
J. Fujii,
W. Wachsman, and I. S. Y. Chen.
1988.
HTLV-II trans-activation is regulated by two overlapping nonstructural genes.
Science
240:916-919[Abstract/Free Full Text].
|
| 41.
|
Ross, T. M.,
S. M. Pettiford, and P. L. Green.
1996.
The tax gene of human T-cell leukemia virus type 2 is essential for transformation of human T lymphocytes.
J. Virol.
70:5194-5202[Abstract/Free Full Text].
|
| 42.
|
Shima, H.,
M. Takano,
K. Shimotohno, and M. Miwa.
1986.
Identification of p26xb and p24xb of human T-cell leukemia virus type II.
FEBS Lett.
209:289-294[CrossRef][Medline].
|
| 43.
|
Siomi, H.,
H. Shida,
S. H. Nam,
T. Nosaka,
M. Maki, and M. Hatanaka.
1988.
Sequence requirements for nucleolar localization of human T-cell leukemia virus type I pX protein which regulates viral RNA processing.
Cell
55:197-209[CrossRef][Medline].
|
| 44.
|
Smith, C. L.,
C. Debouck,
M. Rosenberg, and J. S. Culp.
1989.
Phosphorylation of serine residue 89 of human adenovirus E1A proteins is responsible for their characteristic electrophoretic mobility shifts, and its mutation affects biological function.
J. Virol.
63:1569-1577[Abstract/Free Full Text].
|
| 45.
|
Trejo, S. R.,
W. E. Fahl, and L. Ratner.
1996.
c-sis/PDGF-B promoter transactivation by the Yax protein of human T-cell leukemia virus type 1.
J. Biol. Chem.
271:14584-14590[Abstract/Free Full Text].
|
| 46.
|
Volkman, B. F.,
D. Lipson,
D. E. Wemmer, and D. Kern.
2001.
Two-state allosteric behavior in a single-domain signaling protein.
Science
291:2429-2433[Abstract/Free Full Text].
|
| 47.
|
Wano, Y.,
M. Feinberg,
J. B. Hosking,
H. Bogerd, and W. C. Greene.
1988.
Stable expression of the HTLV-I Tax protein in human T-cells activates specific cellular genes involved in growth.
Proc. Natl. Acad. Sci. USA
85:9733-9737[Abstract/Free Full Text].
|
| 48.
|
Weichselbraun, I.,
J. Berger,
M. Dobrovnik,
H. Bogerd,
R. Grassmann,
W. C. Greene,
J. Hauber, and E. Bohnlein.
1992.
Dominant-negative mutants are clustered in a domain of the human T-cell leukemia virus type I Rex protein: implications for trans dominance.
J. Virol.
66:4540-4545[Abstract/Free Full Text].
|
| 49.
|
Yip, M. T.,
W. S. Dynan,
P. L. Green,
A. C. Black,
S. J. Arrigo,
A. Torbati,
S. Heaphy,
C. Ruland,
J. D. Rosenblatt, and I. S. Y. Chen.
1991.
Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type 1 Rev-responsive element.
J. Virol.
65:2261-2272[Abstract/Free Full Text].
|